Cargando…
Lung Transplantation in Coronavirus-19 Patients: What We Have Learned So Far
Coronavirus-19 (COVID-19) can result in irrecoverable acute respiratory distress syndrome (ARDS) or life-limiting fibrosis for which lung transplantation is currently the only viable treatment. COVID-19 lung transplantation has transformed the field of lung transplantation, as before the pandemic, f...
Autores principales: | Cerier, Emily, Lung, Kalvin, Kurihara, Chitaru, Bharat, Ankit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678827/ https://www.ncbi.nlm.nih.gov/pubmed/37085224 http://dx.doi.org/10.1016/j.ccm.2022.11.017 |
Ejemplares similares
-
Recipient, donor, and surgical factors leading to primary graft dysfunction after lung transplant
por: Toyoda, Takahide, et al.
Publicado: (2023) -
COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020) -
The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013) -
Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015) -
Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
por: Conde, João, et al.
Publicado: (2016)